SNP information rs9332377

Research and publications:

  18436194   Catechol-O-methyltransferase contributes to genetic susceptibility shared among anxiety spectrum phenotypes

  18937309   Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study.

  19015200   Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer.

  19898482   Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.

  20083391   A reappraisal of the association between Dysbindin (DTNBP1) and schizophrenia in a large combined case-control and family-based sample of German ancestry.

  20551675   Localizing putative markers in genetic association studies by incorporating linkage disequilibrium into bayesian hierarchical models.

  20667552   Catechol-o-methyltransferase gene modulation on suicidal behavior and personality traits: review, meta-analysis and association study.

  20877297   Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response.

  21302343   The ATXN1 and TRIM31 genes are related to intelligence in an ADHD background: evidence from a large collaborative study totaling 4,963 subjects.

  21656904   Association between polymorphisms in catechol-O-methyltransferase (COMT) and cocaine-induced paranoia in European-American and African-American populations.

  21787192   Pharmacogenomics of cisplatin-induced ototoxicity.

  21980013   Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors.

  23248619   Chemotherapy refractory testicular germ cell tumor is associated with a variant in Armadillo Repeat gene deleted in Velco-Cardio-Facial syndrome (ARVCF).

  23588304   Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children.

  23932573   Dopaminergic gene polymorphisms and cognitive function in a north Indian schizophrenia cohort.

  24795743   Pharmacogenomics and adverse drug reactions in children.

  24944790   Screening for 392 polymorphisms in 141 pharmacogenes.

  25452763   Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?

  25551397   Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts.

  27720787   Associations Between Neurotransmitter Genes and Fatigue and Energy Levels in Women After Breast Cancer Surgery.

  28445188   TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity.

  29350448   Clinical and genetic associations for carboplatin-related ototoxicity in children treated for retinoblastoma: A retrospective noncomparative single-institute experience.

  30732962   Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients.

  30790653   Usefulness of COMT gene polymorphisms in North African populations.

  31264537   Polymorphisms in COMT, ADRB2 and HTR1A genes are associated with temporomandibular disorders in individuals with other arthralgias.

  31285095   Evaluation of genetic risk related to catechol-O-methyltransferase (COMT) and β2-adrenergic receptor (ADRB2) activity in different diagnostic subgroups of temporomandibular disorder in Brazilian patients.

  32230800   Influence of Genetic Variation in COMT on Cisplatin-Induced Nephrotoxicity in Cancer Patients.

  32961632   Is catechol-O-methyltransferase gene associated with temporomandibular disorders? A systematic review and meta-analysis.

  33262486   Abstracts from the 53rd European Society of Human Genetics (ESHG) Conference: e-Posters.

  34824904   Genetic diversity of "highly important pharmacogenes" in two South Asian populations.

  35848345   Sex hormone-related polymorphisms in endometriosis and migraine: A narrative review.